Репозиторий БГМУ
    • русский
    • English
  • русский 
    • русский
    • English
  • Войти
Просмотр элемента 
  •   Главная
  • Периодические издания БГМУ
  • Неотложная кардиология и кардиоваскулярные риски
  • Неотложная кардиология и кардиоваскулярные риски. 2021
  • Неотложная кардиология и кардиоваскулярные риски. 2021. Т. 5, № 2.
  • Просмотр элемента
  •   Главная
  • Периодические издания БГМУ
  • Неотложная кардиология и кардиоваскулярные риски
  • Неотложная кардиология и кардиоваскулярные риски. 2021
  • Неотложная кардиология и кардиоваскулярные риски. 2021. Т. 5, № 2.
  • Просмотр элемента
JavaScript is disabled for your browser. Some features of this site may not work without it.

Dyslipidemia in liver transplant recipients

Thumbnail
Открыть
1270_1273.pdf (224.4Kb)
Дата
2021
Автор
Grigorenko, E.
Shalimova, A.
Rummo, O.
Mitkovskaya, N.
Metadata
Показать полную информацию

Аннотации

Liver transplant is known to be the only radical treatment for patients with end-stage liver diseases. It is known that cardiovascular diseases rank third among patients, who underwent liver transplant. Due to the current generally accepted policy of aggressive treatment of hypercholesterolemia, mortality from cardiovascular diseases has been significantly reduced in general population. Statin therapy has also demonstrated a de- creasing effect on mortality among patients with chronic liver failure. Recently published research results have shown the increasing occurrence of non-com- municable diseases among liver recipients, including diseases that determine cardiovascular mortality (arterial hypertension, chronic coronary syndrome, chronic heart failure, chronic kidney failure). This evidence demonstrates that in post-operative period doctors should do their best to identify not only traditional risk factors of acute transplant rejection, but also pay attention to cardiovascular risks and their timely treatment. Based on the data about a number of differences in the incidence of cardiovascular risk factors and on the specifics of confirmation and treatment of chronic coronary heart disease in liver transplant recipients in comparison with the general population, we believe that in transplant centers it is necessary to develop a specialized algorithm of dispensary follow-up of recipients (checklist) for adequate prevention of diseases of the circulatory system.

Библиографическое описание

Grigorenko E., Shalimova A., Rummo O., Mitkovskaya N. Dyslipidemia in liver transplant recipients. Неотложная кардиология и кардиоваскулярные риски, 2021, Т. 5, № 2, С. 1270–1273. doi: 10.51922/2616-633X.2021.5.2.1270.
URI
https://rep.bsmu.by/handle/BSMU/34995
Collections
  • Научные публикации ученых БГМУ. 2021 [21]
  • Неотложная кардиология и кардиоваскулярные риски. 2021. Т. 5, № 2. [23]

Белорусский государственный медицинский университет | Библиотека БГМУ | Контакты
 

 

ISSN 2521-6562 online

Просмотр

Весь РепозиторийРазделы и коллекцииДата публикацииАвторыНазванияТематикаЭта коллекцияДата публикацииАвторыНазванияТематика

Моя учетная запись

ВойтиРегистрация

Индексация

Google ScholarOpenDOARROAD ISSNrepositories.webometrics.info

Белорусский государственный медицинский университет | Библиотека БГМУ | Контакты